Jinan, China

Zhaofeng Ding

This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhaofeng Ding. Retrieved from https://idiyas.com/inventor/zhaofeng-ding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhaofeng Ding: Innovator in Pharmaceutical Chemistry

Introduction

Zhaofeng Ding is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work focuses on enhancing the efficacy and safety of pharmaceutical formulations.

Latest Patents

Zhaofeng Ding holds a patent for a crystal form of a spirocyclic amine aryl phosphorus oxide compound. The patent, titled "Crystal form of spirocyclic amine aryl phosphorus oxide compound and preparation method therefor," relates to a specific compound formula. This invention includes a pharmaceutical composition of the crystal form and outlines its pharmaceutical uses and preparation methods. He has 1 patent to his name.

Career Highlights

Zhaofeng Ding is currently employed at Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His role involves research and development, where he applies his expertise to create innovative solutions for medical challenges.

Collaborations

Zhaofeng has collaborated with Qiang Fu, a fellow researcher, to advance their work in pharmaceutical chemistry. Their partnership has contributed to the development of new compounds and formulations.

Conclusion

Zhaofeng Ding's contributions to pharmaceutical chemistry exemplify the importance of innovation in the field. His patent and ongoing work at Qilu Pharmaceutical Co., Ltd. highlight his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…